相关实验视频

Updated: Jul 20, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

使用多中心研究的综合分析来确定与RNA甲基化相关的IncRNA质瘤风险分层系统

Fanxuan Huang¹, Xinyu Wang^1,2, Junzhe Zhong^1,2

¹Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150086, China.

Cancer cell international

|August 4, 2023

概括

这项研究确定了关键的RNA甲基化相关的长非编码RNA (lncRNAs),这些RNA会影响质瘤的预后. 这些lncRNAs可以预测患者的生存率和影响治疗反应,为质瘤免疫疗法提供潜在的新途径.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因组学就是基因组学.

背景情况:

RNA甲基化,包括N6-甲基亚丁素 (m6A),5-甲基亚丁素 (m5C) 和N1-甲基亚丁素 (m1A),在癌症进展中起着至关重要的作用.
与RNA甲基化相关的长非编码RNAs (lncRNAs) 对质瘤预后的具体影响在很大程度上仍未确定.

研究的目的:

调查与RNA甲基化相关的IncRNAs在质瘤中的预后影响.
为质瘤患者开发基于这些 lncRNA 的预后特征.
探索这些lncRNAs与免疫功能,免疫治疗反应和质瘤中药物敏感性的相关性.

主要方法:

利用癌症基因组图谱 (TCGA) 数据库来获取RNA测序数据和32个RNA甲基化相关基因的临床信息.
采用差异表达分析和加权基因共同表达网络分析 (WGCNA) 来识别关键的lncRNAs.
进行了体外和体内实验,以验证特定 lncRNAs 在质瘤中的功能作用.

主要成果:

构建了一个包括十个RNA甲基化相关的lncRNAs的预后签名,证明了对患者存活的良好独立预测能力.
在所有队列中,高风险组的患者与低风险组相比,整体存活率 (OS) 显著降低.
鉴定到的lncRNA与免疫功能,免疫疗法反应和 glioma 亚组中的药物敏感性相关. 淘汰RP11-98I9.4和RP11-752G15.8促进了质瘤细胞的入侵,生长和对temozolomide (TMZ) 的抵抗.
在质瘤细胞中观察到全球m5C和m6ARNA水平升高.

结论:

建立了基于RNA甲基化相关的lncRNAs的质瘤预后模型,突出了它们的预后意义.
证明了RP11-98I9.4和RP11-752G15.8作为质瘤增殖,迁移和TMZ抵抗的抑制剂.
这些与RNA甲基化相关的lncRNAs代表了质瘤免疫治疗的潜在新标.

关键词:

化疗化疗是一种化学疗法.质瘤是一种质瘤.免疫治疗是一种免疫疗法.在 LncRNAs 中.预测预后预测预测通过RNA甲基化.

更多相关视频

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

相关概念视频

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...